Glymphatic Dysfunction, Brain Damage, and Clinical Disability in Spinocerebellar Ataxia Type 3

Documenti analoghi

• Dentate Nucleus Deep Brain Stimulation for Spinocerebellar Ataxia: Results of a 6‐Month Follow‐Up
  di: Liang Zhao, et al.
  Pubblicazione: (2025)
• A Severity‐Agnostic Atrophy Pattern in Spinocerebellar Ataxia Type 3: Volumetrics from ENIGMA ‐Ataxia
  di: Jason W. Robertson, et al.
  Pubblicazione: (2026)
• The Pattern and Stages of Atrophy in Spinocerebellar Ataxia Type 2: Volumetrics from ENIGMA‐Ataxia
  di: Jason W. Robertson, et al.
  Pubblicazione: (2025)
• Dysregulated Cerebrospinal Fluid Proteome of Spinocerebellar Ataxia Type 2 and its Clinical Implications
  di: Albert Stezin, et al.
  Pubblicazione: (2024)
• Decreased Peripheral Blood Lymphocytes in Spinocerebellar Ataxia Type 3 Correlate with Disease Severity
  di: Qi Deng, et al.
  Pubblicazione: (2025)